InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by WELCH DANIEL G, Director. Director active across 2 companies, notably Seagen Inc.. In total, 6 reports have been logged. The latest transaction was filed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
03,300 shares0
Common Stock
SEC:0001209191-22-039568:0·
01,503 shares0
Common Stock
SEC:0000899243-22-018459:0·
02,145 shares0
Common Stock
SEC:0001209191-21-043549·
02,145 shares0
Common Stock
SEC:0001209191-21-043549:0·
01,402 shares0
Common Stock
SEC:0001203311-21-000030·
01,402 shares0
Common Stock
SEC:0001203311-21-000030:0·
6 of 6 declarations
About WELCH DANIEL G
Daniel G. Welch is a Director of Seagen Inc. and Ultragenyx Pharmaceutical Inc. In this role, he participates in the governance and strategy of these companies, bringing his expertise in the pharmaceutical sector.
